AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published November 11, 2008

American Journal of Neuroradiology 2009;30:404.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajnr.A1357v1
30/2/404    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuan, Y.
Right arrow Articles by Wei, W.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuan, Y.
Right arrow Articles by Wei, W.-S.

FUNCTIONAL

Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis

Y. Yuan, Z.-X. Gu and W.-S. Wei

From the Departments of Nuclear Medicine (Y.Y., Z.-X.G.) and Neurology (W.-S.W.), Huadong Hospital, Fudan University, Shanghai, China.

Please address correspondence to Zhao-Xiang Gu, PhD, Department of Nuclear Medicine, Huadong Hospital, Fudan University, 221 W Yan'an Rd, Shanghai, China; e-mail: guzx2222{at}yahoo.com.cn

BACKGROUND AND PURPOSE: Patients with mild cognitive impairment (MCI) are at risk for developing Alzheimer disease (AD). To diagnose AD at an early stage, one must develop highly specific and sensitive tools to identify it among at-risk subjects. The purpose of this study was to evaluate and compare the ability of fluorodeoxyglucose–positron-emission tomography (FDG-PET), single-photon emission tomography (SPECT), and structural MR imaging to predict conversion to AD in patients with MCI.

MATERIALS AND METHODS: Relevant studies were identified with MEDLINE from January 1990 to April 2008. Meta-analysis and meta-regression were done on the diagnostic performance data for each technique from eligible studies. We estimated and compared the weighted summary sensitivities, specificities, likelihood ratios (LRs), and summary receiver operating characteristic curves of each imaging technique.

RESULTS: Twenty-four eligible studies were included, with a total of 1112 patients. FDG-PET performed statistically better in LR+ and odds ratio (OR), whereas no statistical difference was found in pooled sensitivity, specificity, and LR– for each technique. No statistical difference was confirmed between SPECT and MR imaging. The Q* index estimates for FDG-PET, SPECT, and structural MR imaging were respectively 0.86, 0.75, and 0.76. In meta-regression, statistical significance was found only between technique and log OR, with a regression coefficient of –0.575.

CONCLUSIONS: This meta-analysis showed that FDG-PET performs slightly better than SPECT and structural MR imaging in the prediction of conversion to AD in patients with MCI; parallel performance was found between SPECT and MR imaging.




This article has been cited by other articles:


Home page
NeurologyHome page
P. J. Visser and D. S. Knopman
Amyloid imaging in the prediction of Alzheimer-type dementia in subjects with amnestic MCI
Neurology, September 8, 2009; 73(10): 744 - 745.
[Full Text] [PDF]